nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—OPRM1—epilepsy syndrome	0.192	0.721	CbGaD
Ondansetron—CYP2D6—epilepsy syndrome	0.0742	0.279	CbGaD
Ondansetron—CYP2E1—Felbamate—epilepsy syndrome	0.0185	0.0417	CbGbCtD
Ondansetron—CYP2E1—Trimethadione—epilepsy syndrome	0.0185	0.0417	CbGbCtD
Ondansetron—CYP2E1—Clonazepam—epilepsy syndrome	0.0157	0.0355	CbGbCtD
Ondansetron—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0154	0.0349	CbGbCtD
Ondansetron—CYP3A7—Carbamazepine—epilepsy syndrome	0.0129	0.0292	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0129	0.0292	CbGbCtD
Ondansetron—CYP2E1—Rufinamide—epilepsy syndrome	0.0128	0.0289	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0116	0.0262	CbGbCtD
Ondansetron—CYP3A7—Phenytoin—epilepsy syndrome	0.0116	0.0262	CbGbCtD
Ondansetron—CYP2E1—Propofol—epilepsy syndrome	0.0104	0.0236	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0103	0.0233	CbGbCtD
Ondansetron—CYP3A7—Phenobarbital—epilepsy syndrome	0.0103	0.0233	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0102	0.023	CbGbCtD
Ondansetron—CYP3A7—Midazolam—epilepsy syndrome	0.0102	0.023	CbGbCtD
Ondansetron—CYP2E1—Phenobarbital—epilepsy syndrome	0.00996	0.0225	CbGbCtD
Ondansetron—CYP2E1—Midazolam—epilepsy syndrome	0.00982	0.0222	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00978	0.0221	CbGbCtD
Ondansetron—CYP3A7—Diazepam—epilepsy syndrome	0.00978	0.0221	CbGbCtD
Ondansetron—CYP3A5—Carbamazepine—epilepsy syndrome	0.00968	0.0219	CbGbCtD
Ondansetron—CYP2C9—Trimethadione—epilepsy syndrome	0.00961	0.0217	CbGbCtD
Ondansetron—CYP2E1—Diazepam—epilepsy syndrome	0.00944	0.0214	CbGbCtD
Ondansetron—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00904	0.0204	CbGbCtD
Ondansetron—CYP3A5—Phenytoin—epilepsy syndrome	0.00869	0.0196	CbGbCtD
Ondansetron—CYP3A5—Phenobarbital—epilepsy syndrome	0.00774	0.0175	CbGbCtD
Ondansetron—CYP3A5—Midazolam—epilepsy syndrome	0.00763	0.0173	CbGbCtD
Ondansetron—CYP3A5—Diazepam—epilepsy syndrome	0.00734	0.0166	CbGbCtD
Ondansetron—CYP1A2—Carbamazepine—epilepsy syndrome	0.00721	0.0163	CbGbCtD
Ondansetron—CYP1A2—Primidone—epilepsy syndrome	0.00673	0.0152	CbGbCtD
Ondansetron—CYP2C9—Carbamazepine—epilepsy syndrome	0.00649	0.0147	CbGbCtD
Ondansetron—CYP2C9—Primidone—epilepsy syndrome	0.00606	0.0137	CbGbCtD
Ondansetron—CYP1A2—Propofol—epilepsy syndrome	0.00603	0.0136	CbGbCtD
Ondansetron—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00601	0.0136	CbGbCtD
Ondansetron—CYP2C9—Phenytoin—epilepsy syndrome	0.00582	0.0132	CbGbCtD
Ondansetron—CYP3A5—Valproic Acid—epilepsy syndrome	0.00579	0.0131	CbGbCtD
Ondansetron—CYP1A2—Phenobarbital—epilepsy syndrome	0.00576	0.013	CbGbCtD
Ondansetron—CYP3A4—Trimethadione—epilepsy syndrome	0.00559	0.0126	CbGbCtD
Ondansetron—CYP3A4—Felbamate—epilepsy syndrome	0.00559	0.0126	CbGbCtD
Ondansetron—CYP1A2—Diazepam—epilepsy syndrome	0.00546	0.0124	CbGbCtD
Ondansetron—CYP2C9—Propofol—epilepsy syndrome	0.00543	0.0123	CbGbCtD
Ondansetron—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00526	0.0119	CbGbCtD
Ondansetron—CYP2C9—Phenobarbital—epilepsy syndrome	0.00519	0.0117	CbGbCtD
Ondansetron—CYP2D6—Propofol—epilepsy syndrome	0.00497	0.0112	CbGbCtD
Ondansetron—CYP2C9—Diazepam—epilepsy syndrome	0.00492	0.0111	CbGbCtD
Ondansetron—CYP3A4—Clonazepam—epilepsy syndrome	0.00475	0.0107	CbGbCtD
Ondansetron—CYP3A4—Clobazam—epilepsy syndrome	0.00456	0.0103	CbGbCtD
Ondansetron—CYP1A2—Valproic Acid—epilepsy syndrome	0.00431	0.00974	CbGbCtD
Ondansetron—CYP2C9—Valproic Acid—epilepsy syndrome	0.00388	0.00877	CbGbCtD
Ondansetron—CYP3A4—Rufinamide—epilepsy syndrome	0.00387	0.00876	CbGbCtD
Ondansetron—CYP3A4—Carbamazepine—epilepsy syndrome	0.00378	0.00854	CbGbCtD
Ondansetron—CYP3A4—Primidone—epilepsy syndrome	0.00353	0.00797	CbGbCtD
Ondansetron—HTR3A—vagus nerve—epilepsy syndrome	0.00347	0.0856	CbGeAlD
Ondansetron—CYP3A4—Phenytoin—epilepsy syndrome	0.00339	0.00766	CbGbCtD
Ondansetron—CYP3A4—Propofol—epilepsy syndrome	0.00316	0.00714	CbGbCtD
Ondansetron—CYP3A4—Phenobarbital—epilepsy syndrome	0.00302	0.00683	CbGbCtD
Ondansetron—CYP3A4—Acetazolamide—epilepsy syndrome	0.00302	0.00683	CbGbCtD
Ondansetron—CYP3A4—Midazolam—epilepsy syndrome	0.00298	0.00673	CbGbCtD
Ondansetron—CYP3A4—Diazepam—epilepsy syndrome	0.00286	0.00647	CbGbCtD
Ondansetron—CYP3A4—Zonisamide—epilepsy syndrome	0.00279	0.00632	CbGbCtD
Ondansetron—CYP3A4—Valproic Acid—epilepsy syndrome	0.00226	0.0051	CbGbCtD
Ondansetron—CYP3A4—Topiramate—epilepsy syndrome	0.00204	0.0046	CbGbCtD
Ondansetron—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00197	0.0486	CbGeAlD
Ondansetron—HTR4—telencephalon—epilepsy syndrome	0.00191	0.0471	CbGeAlD
Ondansetron—HTR1B—telencephalic ventricle—epilepsy syndrome	0.0018	0.0445	CbGeAlD
Ondansetron—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00145	0.0359	CbGeAlD
Ondansetron—HTR3A—ganglion—epilepsy syndrome	0.00134	0.033	CbGeAlD
Ondansetron—OPRM1—ganglion—epilepsy syndrome	0.00123	0.0303	CbGeAlD
Ondansetron—HTR1B—ganglion—epilepsy syndrome	0.00112	0.0277	CbGeAlD
Ondansetron—SLC47A1—hindbrain—epilepsy syndrome	0.000996	0.0246	CbGeAlD
Ondansetron—HTR1A—ganglion—epilepsy syndrome	0.000905	0.0223	CbGeAlD
Ondansetron—SLC47A2—head—epilepsy syndrome	0.000901	0.0222	CbGeAlD
Ondansetron—HTR4—brain—epilepsy syndrome	0.000862	0.0213	CbGeAlD
Ondansetron—SLC47A2—nervous system—epilepsy syndrome	0.000855	0.0211	CbGeAlD
Ondansetron—SLC47A2—central nervous system—epilepsy syndrome	0.000823	0.0203	CbGeAlD
Ondansetron—HTR1A—hindbrain—epilepsy syndrome	0.000686	0.0169	CbGeAlD
Ondansetron—SLC47A2—brain—epilepsy syndrome	0.000653	0.0161	CbGeAlD
Ondansetron—HTR3A—brainstem—epilepsy syndrome	0.000581	0.0143	CbGeAlD
Ondansetron—SLC47A1—brainstem—epilepsy syndrome	0.000571	0.0141	CbGeAlD
Ondansetron—HTR3A—forebrain—epilepsy syndrome	0.000561	0.0138	CbGeAlD
Ondansetron—OPRM1—brainstem—epilepsy syndrome	0.000533	0.0132	CbGeAlD
Ondansetron—HTR3A—telencephalon—epilepsy syndrome	0.000516	0.0127	CbGeAlD
Ondansetron—OPRM1—forebrain—epilepsy syndrome	0.000514	0.0127	CbGeAlD
Ondansetron—HTR1B—brainstem—epilepsy syndrome	0.000487	0.012	CbGeAlD
Ondansetron—OPRM1—telencephalon—epilepsy syndrome	0.000473	0.0117	CbGeAlD
Ondansetron—HTR1B—forebrain—epilepsy syndrome	0.00047	0.0116	CbGeAlD
Ondansetron—HTR1B—telencephalon—epilepsy syndrome	0.000433	0.0107	CbGeAlD
Ondansetron—SLC47A1—medulla oblongata—epilepsy syndrome	0.000398	0.00982	CbGeAlD
Ondansetron—HTR1A—brainstem—epilepsy syndrome	0.000393	0.00971	CbGeAlD
Ondansetron—HTR1A—forebrain—epilepsy syndrome	0.00038	0.00937	CbGeAlD
Ondansetron—CYP2D6—hindbrain—epilepsy syndrome	0.000373	0.0092	CbGeAlD
Ondansetron—SLC47A1—spinal cord—epilepsy syndrome	0.000355	0.00876	CbGeAlD
Ondansetron—HTR1A—telencephalon—epilepsy syndrome	0.000349	0.00862	CbGeAlD
Ondansetron—OPRM1—midbrain—epilepsy syndrome	0.00034	0.00838	CbGeAlD
Ondansetron—KCNH2—forebrain—epilepsy syndrome	0.000338	0.00834	CbGeAlD
Ondansetron—OPRM1—spinal cord—epilepsy syndrome	0.000331	0.00818	CbGeAlD
Ondansetron—HTR3A—head—epilepsy syndrome	0.000321	0.00793	CbGeAlD
Ondansetron—SLC47A1—head—epilepsy syndrome	0.000315	0.00779	CbGeAlD
Ondansetron—KCNH2—telencephalon—epilepsy syndrome	0.000311	0.00767	CbGeAlD
Ondansetron—HTR1B—midbrain—epilepsy syndrome	0.000311	0.00767	CbGeAlD
Ondansetron—HTR3A—nervous system—epilepsy syndrome	0.000304	0.00751	CbGeAlD
Ondansetron—HTR1B—spinal cord—epilepsy syndrome	0.000303	0.00748	CbGeAlD
Ondansetron—SLC47A1—nervous system—epilepsy syndrome	0.000299	0.00738	CbGeAlD
Ondansetron—OPRM1—head—epilepsy syndrome	0.000294	0.00727	CbGeAlD
Ondansetron—HTR3A—central nervous system—epilepsy syndrome	0.000293	0.00723	CbGeAlD
Ondansetron—SLC47A1—central nervous system—epilepsy syndrome	0.000288	0.00711	CbGeAlD
Ondansetron—SLC47A1—cerebellum—epilepsy syndrome	0.000281	0.00695	CbGeAlD
Ondansetron—OPRM1—nervous system—epilepsy syndrome	0.000279	0.00689	CbGeAlD
Ondansetron—HTR1B—head—epilepsy syndrome	0.000269	0.00665	CbGeAlD
Ondansetron—OPRM1—central nervous system—epilepsy syndrome	0.000269	0.00663	CbGeAlD
Ondansetron—HTR1B—nervous system—epilepsy syndrome	0.000255	0.0063	CbGeAlD
Ondansetron—HTR1A—midbrain—epilepsy syndrome	0.000251	0.00619	CbGeAlD
Ondansetron—HTR1B—central nervous system—epilepsy syndrome	0.000246	0.00607	CbGeAlD
Ondansetron—HTR1A—spinal cord—epilepsy syndrome	0.000245	0.00604	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—epilepsy syndrome	0.000244	0.00603	CbGeAlD
Ondansetron—CYP2E1—telencephalon—epilepsy syndrome	0.000239	0.00591	CbGeAlD
Ondansetron—HTR3A—brain—epilepsy syndrome	0.000233	0.00574	CbGeAlD
Ondansetron—SLC47A1—brain—epilepsy syndrome	0.000229	0.00564	CbGeAlD
Ondansetron—KCNH2—midbrain—epilepsy syndrome	0.000223	0.00551	CbGeAlD
Ondansetron—KCNH2—spinal cord—epilepsy syndrome	0.000218	0.00538	CbGeAlD
Ondansetron—HTR1A—head—epilepsy syndrome	0.000217	0.00537	CbGeAlD
Ondansetron—CYP2D6—brainstem—epilepsy syndrome	0.000214	0.00527	CbGeAlD
Ondansetron—OPRM1—brain—epilepsy syndrome	0.000213	0.00527	CbGeAlD
Ondansetron—CYP2D6—forebrain—epilepsy syndrome	0.000206	0.00509	CbGeAlD
Ondansetron—HTR1A—nervous system—epilepsy syndrome	0.000206	0.00509	CbGeAlD
Ondansetron—HTR1A—central nervous system—epilepsy syndrome	0.000198	0.0049	CbGeAlD
Ondansetron—HTR1B—brain—epilepsy syndrome	0.000195	0.00482	CbGeAlD
Ondansetron—HTR1A—cerebellum—epilepsy syndrome	0.000194	0.00479	CbGeAlD
Ondansetron—KCNH2—head—epilepsy syndrome	0.000194	0.00478	CbGeAlD
Ondansetron—CYP2D6—telencephalon—epilepsy syndrome	0.00019	0.00468	CbGeAlD
Ondansetron—CYP2E1—medulla oblongata—epilepsy syndrome	0.000188	0.00464	CbGeAlD
Ondansetron—KCNH2—nervous system—epilepsy syndrome	0.000183	0.00453	CbGeAlD
Ondansetron—KCNH2—central nervous system—epilepsy syndrome	0.000177	0.00436	CbGeAlD
Ondansetron—KCNH2—cerebellum—epilepsy syndrome	0.000173	0.00426	CbGeAlD
Ondansetron—CYP2E1—spinal cord—epilepsy syndrome	0.000168	0.00414	CbGeAlD
Ondansetron—HTR1A—brain—epilepsy syndrome	0.000158	0.00389	CbGeAlD
Ondansetron—CYP2E1—head—epilepsy syndrome	0.000149	0.00368	CbGeAlD
Ondansetron—CYP2E1—nervous system—epilepsy syndrome	0.000141	0.00349	CbGeAlD
Ondansetron—KCNH2—brain—epilepsy syndrome	0.00014	0.00346	CbGeAlD
Ondansetron—CYP2E1—central nervous system—epilepsy syndrome	0.000136	0.00336	CbGeAlD
Ondansetron—CYP2E1—cerebellum—epilepsy syndrome	0.000133	0.00328	CbGeAlD
Ondansetron—CYP2D6—head—epilepsy syndrome	0.000118	0.00291	CbGeAlD
Ondansetron—CYP3A4—nervous system—epilepsy syndrome	0.000114	0.00281	CbGeAlD
Ondansetron—CYP2D6—nervous system—epilepsy syndrome	0.000112	0.00276	CbGeAlD
Ondansetron—CYP3A4—central nervous system—epilepsy syndrome	0.000109	0.0027	CbGeAlD
Ondansetron—CYP2E1—brain—epilepsy syndrome	0.000108	0.00267	CbGeAlD
Ondansetron—CYP2D6—central nervous system—epilepsy syndrome	0.000108	0.00266	CbGeAlD
Ondansetron—CYP2D6—cerebellum—epilepsy syndrome	0.000105	0.0026	CbGeAlD
Ondansetron—CYP2D6—brain—epilepsy syndrome	8.55e-05	0.00211	CbGeAlD
Ondansetron—Body temperature increased—Carbamazepine—epilepsy syndrome	5.6e-05	0.00035	CcSEcCtD
Ondansetron—Diarrhoea—Diazepam—epilepsy syndrome	5.6e-05	0.00035	CcSEcCtD
Ondansetron—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.6e-05	0.00035	CcSEcCtD
Ondansetron—Ill-defined disorder—Pregabalin—epilepsy syndrome	5.59e-05	0.00035	CcSEcCtD
Ondansetron—Rash—Levetiracetam—epilepsy syndrome	5.57e-05	0.000348	CcSEcCtD
Ondansetron—Dermatitis—Levetiracetam—epilepsy syndrome	5.57e-05	0.000348	CcSEcCtD
Ondansetron—Asthenia—Zonisamide—epilepsy syndrome	5.56e-05	0.000348	CcSEcCtD
Ondansetron—Dry mouth—Valproic Acid—epilepsy syndrome	5.55e-05	0.000347	CcSEcCtD
Ondansetron—Agitation—Pregabalin—epilepsy syndrome	5.54e-05	0.000346	CcSEcCtD
Ondansetron—Headache—Levetiracetam—epilepsy syndrome	5.54e-05	0.000346	CcSEcCtD
Ondansetron—Erythema—Gabapentin—epilepsy syndrome	5.53e-05	0.000346	CcSEcCtD
Ondansetron—Angioedema—Pregabalin—epilepsy syndrome	5.51e-05	0.000344	CcSEcCtD
Ondansetron—Hypersensitivity—Clonazepam—epilepsy syndrome	5.5e-05	0.000344	CcSEcCtD
Ondansetron—Dizziness—Vigabatrin—epilepsy syndrome	5.5e-05	0.000344	CcSEcCtD
Ondansetron—Pruritus—Zonisamide—epilepsy syndrome	5.48e-05	0.000343	CcSEcCtD
Ondansetron—Hypersensitivity—Phenytoin—epilepsy syndrome	5.47e-05	0.000342	CcSEcCtD
Ondansetron—Flatulence—Gabapentin—epilepsy syndrome	5.45e-05	0.000341	CcSEcCtD
Ondansetron—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.44e-05	0.00034	CcSEcCtD
Ondansetron—Urticaria—Lamotrigine—epilepsy syndrome	5.44e-05	0.00034	CcSEcCtD
Ondansetron—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.44e-05	0.00034	CcSEcCtD
Ondansetron—Bradycardia—Topiramate—epilepsy syndrome	5.44e-05	0.00034	CcSEcCtD
Ondansetron—Malaise—Pregabalin—epilepsy syndrome	5.43e-05	0.00034	CcSEcCtD
Ondansetron—Vomiting—Fosphenytoin—epilepsy syndrome	5.42e-05	0.000339	CcSEcCtD
Ondansetron—Diarrhoea—Felbamate—epilepsy syndrome	5.42e-05	0.000339	CcSEcCtD
Ondansetron—Body temperature increased—Lamotrigine—epilepsy syndrome	5.41e-05	0.000338	CcSEcCtD
Ondansetron—Abdominal pain—Lamotrigine—epilepsy syndrome	5.41e-05	0.000338	CcSEcCtD
Ondansetron—Dizziness—Diazepam—epilepsy syndrome	5.41e-05	0.000338	CcSEcCtD
Ondansetron—Syncope—Pregabalin—epilepsy syndrome	5.4e-05	0.000338	CcSEcCtD
Ondansetron—Rash—Fosphenytoin—epilepsy syndrome	5.38e-05	0.000336	CcSEcCtD
Ondansetron—Dermatitis—Fosphenytoin—epilepsy syndrome	5.37e-05	0.000336	CcSEcCtD
Ondansetron—Haemoglobin—Topiramate—epilepsy syndrome	5.37e-05	0.000336	CcSEcCtD
Ondansetron—Asthenia—Clonazepam—epilepsy syndrome	5.36e-05	0.000335	CcSEcCtD
Ondansetron—Headache—Fosphenytoin—epilepsy syndrome	5.34e-05	0.000334	CcSEcCtD
Ondansetron—Haemorrhage—Topiramate—epilepsy syndrome	5.34e-05	0.000334	CcSEcCtD
Ondansetron—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.34e-05	0.000334	CcSEcCtD
Ondansetron—Palpitations—Pregabalin—epilepsy syndrome	5.33e-05	0.000333	CcSEcCtD
Ondansetron—Asthenia—Phenytoin—epilepsy syndrome	5.32e-05	0.000333	CcSEcCtD
Ondansetron—Tachycardia—Valproic Acid—epilepsy syndrome	5.31e-05	0.000332	CcSEcCtD
Ondansetron—Diarrhoea—Zonisamide—epilepsy syndrome	5.3e-05	0.000332	CcSEcCtD
Ondansetron—Loss of consciousness—Pregabalin—epilepsy syndrome	5.3e-05	0.000331	CcSEcCtD
Ondansetron—Asthenia—Oxcarbazepine—epilepsy syndrome	5.3e-05	0.000331	CcSEcCtD
Ondansetron—Pruritus—Clonazepam—epilepsy syndrome	5.29e-05	0.000331	CcSEcCtD
Ondansetron—Vomiting—Vigabatrin—epilepsy syndrome	5.28e-05	0.000331	CcSEcCtD
Ondansetron—Skin disorder—Valproic Acid—epilepsy syndrome	5.28e-05	0.00033	CcSEcCtD
Ondansetron—Cough—Pregabalin—epilepsy syndrome	5.26e-05	0.000329	CcSEcCtD
Ondansetron—Pruritus—Phenytoin—epilepsy syndrome	5.25e-05	0.000328	CcSEcCtD
Ondansetron—Rash—Vigabatrin—epilepsy syndrome	5.24e-05	0.000328	CcSEcCtD
Ondansetron—Dizziness—Felbamate—epilepsy syndrome	5.24e-05	0.000328	CcSEcCtD
Ondansetron—Dermatitis—Vigabatrin—epilepsy syndrome	5.24e-05	0.000327	CcSEcCtD
Ondansetron—Pruritus—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000327	CcSEcCtD
Ondansetron—Convulsion—Pregabalin—epilepsy syndrome	5.22e-05	0.000327	CcSEcCtD
Ondansetron—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.22e-05	0.000326	CcSEcCtD
Ondansetron—Vision blurred—Gabapentin—epilepsy syndrome	5.21e-05	0.000326	CcSEcCtD
Ondansetron—Headache—Vigabatrin—epilepsy syndrome	5.21e-05	0.000326	CcSEcCtD
Ondansetron—Vomiting—Diazepam—epilepsy syndrome	5.2e-05	0.000325	CcSEcCtD
Ondansetron—Tremor—Gabapentin—epilepsy syndrome	5.18e-05	0.000324	CcSEcCtD
Ondansetron—Rash—Diazepam—epilepsy syndrome	5.16e-05	0.000323	CcSEcCtD
Ondansetron—Dermatitis—Diazepam—epilepsy syndrome	5.15e-05	0.000322	CcSEcCtD
Ondansetron—Visual impairment—Topiramate—epilepsy syndrome	5.15e-05	0.000322	CcSEcCtD
Ondansetron—Chest pain—Pregabalin—epilepsy syndrome	5.13e-05	0.000321	CcSEcCtD
Ondansetron—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.13e-05	0.000321	CcSEcCtD
Ondansetron—Dizziness—Zonisamide—epilepsy syndrome	5.13e-05	0.000321	CcSEcCtD
Ondansetron—Headache—Diazepam—epilepsy syndrome	5.13e-05	0.000321	CcSEcCtD
Ondansetron—Anxiety—Pregabalin—epilepsy syndrome	5.11e-05	0.00032	CcSEcCtD
Ondansetron—Diarrhoea—Clonazepam—epilepsy syndrome	5.11e-05	0.00032	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.1e-05	0.000319	CcSEcCtD
Ondansetron—Hypotension—Valproic Acid—epilepsy syndrome	5.08e-05	0.000318	CcSEcCtD
Ondansetron—Asthenia—Carbamazepine—epilepsy syndrome	5.08e-05	0.000318	CcSEcCtD
Ondansetron—Agitation—Gabapentin—epilepsy syndrome	5.08e-05	0.000318	CcSEcCtD
Ondansetron—Diarrhoea—Phenytoin—epilepsy syndrome	5.08e-05	0.000318	CcSEcCtD
Ondansetron—Discomfort—Pregabalin—epilepsy syndrome	5.07e-05	0.000317	CcSEcCtD
Ondansetron—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.05e-05	0.000316	CcSEcCtD
Ondansetron—Erythema multiforme—Topiramate—epilepsy syndrome	5.05e-05	0.000316	CcSEcCtD
Ondansetron—Angioedema—Gabapentin—epilepsy syndrome	5.05e-05	0.000316	CcSEcCtD
Ondansetron—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.04e-05	0.000315	CcSEcCtD
Ondansetron—Vomiting—Felbamate—epilepsy syndrome	5.04e-05	0.000315	CcSEcCtD
Ondansetron—Dry mouth—Pregabalin—epilepsy syndrome	5.02e-05	0.000314	CcSEcCtD
Ondansetron—Pruritus—Carbamazepine—epilepsy syndrome	5.01e-05	0.000313	CcSEcCtD
Ondansetron—Rash—Felbamate—epilepsy syndrome	4.99e-05	0.000312	CcSEcCtD
Ondansetron—Eye disorder—Topiramate—epilepsy syndrome	4.99e-05	0.000312	CcSEcCtD
Ondansetron—Dermatitis—Felbamate—epilepsy syndrome	4.99e-05	0.000312	CcSEcCtD
Ondansetron—Malaise—Gabapentin—epilepsy syndrome	4.98e-05	0.000312	CcSEcCtD
Ondansetron—Headache—Felbamate—epilepsy syndrome	4.96e-05	0.00031	CcSEcCtD
Ondansetron—Cardiac disorder—Topiramate—epilepsy syndrome	4.96e-05	0.00031	CcSEcCtD
Ondansetron—Flushing—Topiramate—epilepsy syndrome	4.96e-05	0.00031	CcSEcCtD
Ondansetron—Syncope—Gabapentin—epilepsy syndrome	4.96e-05	0.00031	CcSEcCtD
Ondansetron—Dizziness—Clonazepam—epilepsy syndrome	4.94e-05	0.000309	CcSEcCtD
Ondansetron—Vomiting—Zonisamide—epilepsy syndrome	4.93e-05	0.000308	CcSEcCtD
Ondansetron—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.92e-05	0.000308	CcSEcCtD
Ondansetron—Asthenia—Lamotrigine—epilepsy syndrome	4.91e-05	0.000307	CcSEcCtD
Ondansetron—Dizziness—Phenytoin—epilepsy syndrome	4.91e-05	0.000307	CcSEcCtD
Ondansetron—Rash—Zonisamide—epilepsy syndrome	4.89e-05	0.000306	CcSEcCtD
Ondansetron—Paraesthesia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000306	CcSEcCtD
Ondansetron—Palpitations—Gabapentin—epilepsy syndrome	4.88e-05	0.000305	CcSEcCtD
Ondansetron—Dermatitis—Zonisamide—epilepsy syndrome	4.88e-05	0.000305	CcSEcCtD
Ondansetron—Dizziness—Oxcarbazepine—epilepsy syndrome	4.88e-05	0.000305	CcSEcCtD
Ondansetron—Loss of consciousness—Gabapentin—epilepsy syndrome	4.86e-05	0.000304	CcSEcCtD
Ondansetron—Headache—Zonisamide—epilepsy syndrome	4.86e-05	0.000304	CcSEcCtD
Ondansetron—Dyspnoea—Valproic Acid—epilepsy syndrome	4.85e-05	0.000303	CcSEcCtD
Ondansetron—Diarrhoea—Carbamazepine—epilepsy syndrome	4.85e-05	0.000303	CcSEcCtD
Ondansetron—Angiopathy—Topiramate—epilepsy syndrome	4.85e-05	0.000303	CcSEcCtD
Ondansetron—Pruritus—Lamotrigine—epilepsy syndrome	4.84e-05	0.000303	CcSEcCtD
Ondansetron—Shock—Pregabalin—epilepsy syndrome	4.84e-05	0.000303	CcSEcCtD
Ondansetron—Somnolence—Valproic Acid—epilepsy syndrome	4.84e-05	0.000302	CcSEcCtD
Ondansetron—Immune system disorder—Topiramate—epilepsy syndrome	4.82e-05	0.000302	CcSEcCtD
Ondansetron—Nervous system disorder—Pregabalin—epilepsy syndrome	4.82e-05	0.000302	CcSEcCtD
Ondansetron—Cough—Gabapentin—epilepsy syndrome	4.82e-05	0.000302	CcSEcCtD
Ondansetron—Mediastinal disorder—Topiramate—epilepsy syndrome	4.81e-05	0.000301	CcSEcCtD
Ondansetron—Tachycardia—Pregabalin—epilepsy syndrome	4.8e-05	0.0003	CcSEcCtD
Ondansetron—Chills—Topiramate—epilepsy syndrome	4.79e-05	0.0003	CcSEcCtD
Ondansetron—Convulsion—Gabapentin—epilepsy syndrome	4.79e-05	0.000299	CcSEcCtD
Ondansetron—Skin disorder—Pregabalin—epilepsy syndrome	4.78e-05	0.000299	CcSEcCtD
Ondansetron—Vomiting—Clonazepam—epilepsy syndrome	4.75e-05	0.000297	CcSEcCtD
Ondansetron—Vomiting—Phenytoin—epilepsy syndrome	4.72e-05	0.000295	CcSEcCtD
Ondansetron—Rash—Clonazepam—epilepsy syndrome	4.71e-05	0.000295	CcSEcCtD
Ondansetron—Dermatitis—Clonazepam—epilepsy syndrome	4.71e-05	0.000294	CcSEcCtD
Ondansetron—Chest pain—Gabapentin—epilepsy syndrome	4.7e-05	0.000294	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.7e-05	0.000294	CcSEcCtD
Ondansetron—Vomiting—Oxcarbazepine—epilepsy syndrome	4.69e-05	0.000294	CcSEcCtD
Ondansetron—Fatigue—Valproic Acid—epilepsy syndrome	4.69e-05	0.000293	CcSEcCtD
Ondansetron—Anxiety—Gabapentin—epilepsy syndrome	4.69e-05	0.000293	CcSEcCtD
Ondansetron—Dizziness—Carbamazepine—epilepsy syndrome	4.68e-05	0.000293	CcSEcCtD
Ondansetron—Diarrhoea—Lamotrigine—epilepsy syndrome	4.68e-05	0.000293	CcSEcCtD
Ondansetron—Headache—Clonazepam—epilepsy syndrome	4.68e-05	0.000293	CcSEcCtD
Ondansetron—Rash—Phenytoin—epilepsy syndrome	4.68e-05	0.000293	CcSEcCtD
Ondansetron—Dermatitis—Phenytoin—epilepsy syndrome	4.68e-05	0.000292	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.67e-05	0.000292	CcSEcCtD
Ondansetron—Rash—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Pain—Valproic Acid—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Constipation—Valproic Acid—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Headache—Phenytoin—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Erythema—Topiramate—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Discomfort—Gabapentin—epilepsy syndrome	4.65e-05	0.000291	CcSEcCtD
Ondansetron—Headache—Oxcarbazepine—epilepsy syndrome	4.62e-05	0.000289	CcSEcCtD
Ondansetron—Dry mouth—Gabapentin—epilepsy syndrome	4.6e-05	0.000288	CcSEcCtD
Ondansetron—Hypotension—Pregabalin—epilepsy syndrome	4.6e-05	0.000287	CcSEcCtD
Ondansetron—Flatulence—Topiramate—epilepsy syndrome	4.58e-05	0.000287	CcSEcCtD
Ondansetron—Dizziness—Lamotrigine—epilepsy syndrome	4.53e-05	0.000283	CcSEcCtD
Ondansetron—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.51e-05	0.000282	CcSEcCtD
Ondansetron—Vomiting—Carbamazepine—epilepsy syndrome	4.5e-05	0.000282	CcSEcCtD
Ondansetron—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.48e-05	0.00028	CcSEcCtD
Ondansetron—Rash—Carbamazepine—epilepsy syndrome	4.47e-05	0.000279	CcSEcCtD
Ondansetron—Dermatitis—Carbamazepine—epilepsy syndrome	4.46e-05	0.000279	CcSEcCtD
Ondansetron—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.45e-05	0.000278	CcSEcCtD
Ondansetron—Headache—Carbamazepine—epilepsy syndrome	4.44e-05	0.000278	CcSEcCtD
Ondansetron—Shock—Gabapentin—epilepsy syndrome	4.44e-05	0.000278	CcSEcCtD
Ondansetron—Nervous system disorder—Gabapentin—epilepsy syndrome	4.42e-05	0.000277	CcSEcCtD
Ondansetron—Paraesthesia—Pregabalin—epilepsy syndrome	4.42e-05	0.000276	CcSEcCtD
Ondansetron—Tachycardia—Gabapentin—epilepsy syndrome	4.4e-05	0.000275	CcSEcCtD
Ondansetron—Dyspnoea—Pregabalin—epilepsy syndrome	4.39e-05	0.000274	CcSEcCtD
Ondansetron—Vision blurred—Topiramate—epilepsy syndrome	4.38e-05	0.000274	CcSEcCtD
Ondansetron—Skin disorder—Gabapentin—epilepsy syndrome	4.38e-05	0.000274	CcSEcCtD
Ondansetron—Somnolence—Pregabalin—epilepsy syndrome	4.37e-05	0.000273	CcSEcCtD
Ondansetron—Tremor—Topiramate—epilepsy syndrome	4.36e-05	0.000272	CcSEcCtD
Ondansetron—Vomiting—Lamotrigine—epilepsy syndrome	4.35e-05	0.000272	CcSEcCtD
Ondansetron—Urticaria—Valproic Acid—epilepsy syndrome	4.32e-05	0.00027	CcSEcCtD
Ondansetron—Rash—Lamotrigine—epilepsy syndrome	4.32e-05	0.00027	CcSEcCtD
Ondansetron—Ill-defined disorder—Topiramate—epilepsy syndrome	4.31e-05	0.00027	CcSEcCtD
Ondansetron—Dermatitis—Lamotrigine—epilepsy syndrome	4.31e-05	0.00027	CcSEcCtD
Ondansetron—Body temperature increased—Valproic Acid—epilepsy syndrome	4.3e-05	0.000269	CcSEcCtD
Ondansetron—Abdominal pain—Valproic Acid—epilepsy syndrome	4.3e-05	0.000269	CcSEcCtD
Ondansetron—Headache—Lamotrigine—epilepsy syndrome	4.29e-05	0.000268	CcSEcCtD
Ondansetron—Agitation—Topiramate—epilepsy syndrome	4.27e-05	0.000267	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.25e-05	0.000266	CcSEcCtD
Ondansetron—Fatigue—Pregabalin—epilepsy syndrome	4.24e-05	0.000265	CcSEcCtD
Ondansetron—Hypotension—Gabapentin—epilepsy syndrome	4.21e-05	0.000264	CcSEcCtD
Ondansetron—Constipation—Pregabalin—epilepsy syndrome	4.21e-05	0.000263	CcSEcCtD
Ondansetron—Pain—Pregabalin—epilepsy syndrome	4.21e-05	0.000263	CcSEcCtD
Ondansetron—Malaise—Topiramate—epilepsy syndrome	4.19e-05	0.000262	CcSEcCtD
Ondansetron—Syncope—Topiramate—epilepsy syndrome	4.17e-05	0.000261	CcSEcCtD
Ondansetron—Palpitations—Topiramate—epilepsy syndrome	4.11e-05	0.000257	CcSEcCtD
Ondansetron—Loss of consciousness—Topiramate—epilepsy syndrome	4.09e-05	0.000256	CcSEcCtD
Ondansetron—Cough—Topiramate—epilepsy syndrome	4.06e-05	0.000254	CcSEcCtD
Ondansetron—Feeling abnormal—Pregabalin—epilepsy syndrome	4.05e-05	0.000253	CcSEcCtD
Ondansetron—Paraesthesia—Gabapentin—epilepsy syndrome	4.05e-05	0.000253	CcSEcCtD
Ondansetron—Convulsion—Topiramate—epilepsy syndrome	4.03e-05	0.000252	CcSEcCtD
Ondansetron—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.02e-05	0.000252	CcSEcCtD
Ondansetron—Dyspnoea—Gabapentin—epilepsy syndrome	4.02e-05	0.000251	CcSEcCtD
Ondansetron—Somnolence—Gabapentin—epilepsy syndrome	4.01e-05	0.000251	CcSEcCtD
Ondansetron—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.01e-05	0.000251	CcSEcCtD
Ondansetron—Chest pain—Topiramate—epilepsy syndrome	3.96e-05	0.000248	CcSEcCtD
Ondansetron—Anxiety—Topiramate—epilepsy syndrome	3.94e-05	0.000247	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.93e-05	0.000246	CcSEcCtD
Ondansetron—Discomfort—Topiramate—epilepsy syndrome	3.91e-05	0.000245	CcSEcCtD
Ondansetron—Urticaria—Pregabalin—epilepsy syndrome	3.91e-05	0.000244	CcSEcCtD
Ondansetron—Asthenia—Valproic Acid—epilepsy syndrome	3.9e-05	0.000244	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.89e-05	0.000244	CcSEcCtD
Ondansetron—Fatigue—Gabapentin—epilepsy syndrome	3.89e-05	0.000243	CcSEcCtD
Ondansetron—Abdominal pain—Pregabalin—epilepsy syndrome	3.89e-05	0.000243	CcSEcCtD
Ondansetron—Body temperature increased—Pregabalin—epilepsy syndrome	3.89e-05	0.000243	CcSEcCtD
Ondansetron—Dry mouth—Topiramate—epilepsy syndrome	3.87e-05	0.000242	CcSEcCtD
Ondansetron—Pain—Gabapentin—epilepsy syndrome	3.86e-05	0.000241	CcSEcCtD
Ondansetron—Constipation—Gabapentin—epilepsy syndrome	3.86e-05	0.000241	CcSEcCtD
Ondansetron—Pruritus—Valproic Acid—epilepsy syndrome	3.85e-05	0.000241	CcSEcCtD
Ondansetron—Shock—Topiramate—epilepsy syndrome	3.73e-05	0.000233	CcSEcCtD
Ondansetron—Diarrhoea—Valproic Acid—epilepsy syndrome	3.72e-05	0.000233	CcSEcCtD
Ondansetron—Nervous system disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000233	CcSEcCtD
Ondansetron—Feeling abnormal—Gabapentin—epilepsy syndrome	3.72e-05	0.000232	CcSEcCtD
Ondansetron—Tachycardia—Topiramate—epilepsy syndrome	3.7e-05	0.000232	CcSEcCtD
Ondansetron—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.69e-05	0.000231	CcSEcCtD
Ondansetron—Skin disorder—Topiramate—epilepsy syndrome	3.69e-05	0.00023	CcSEcCtD
Ondansetron—Hypersensitivity—Pregabalin—epilepsy syndrome	3.62e-05	0.000227	CcSEcCtD
Ondansetron—Dizziness—Valproic Acid—epilepsy syndrome	3.6e-05	0.000225	CcSEcCtD
Ondansetron—Urticaria—Gabapentin—epilepsy syndrome	3.58e-05	0.000224	CcSEcCtD
Ondansetron—Body temperature increased—Gabapentin—epilepsy syndrome	3.57e-05	0.000223	CcSEcCtD
Ondansetron—Abdominal pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000223	CcSEcCtD
Ondansetron—Hypotension—Topiramate—epilepsy syndrome	3.55e-05	0.000222	CcSEcCtD
Ondansetron—Asthenia—Pregabalin—epilepsy syndrome	3.53e-05	0.000221	CcSEcCtD
Ondansetron—Pruritus—Pregabalin—epilepsy syndrome	3.48e-05	0.000218	CcSEcCtD
Ondansetron—Vomiting—Valproic Acid—epilepsy syndrome	3.46e-05	0.000216	CcSEcCtD
Ondansetron—Rash—Valproic Acid—epilepsy syndrome	3.43e-05	0.000215	CcSEcCtD
Ondansetron—Dermatitis—Valproic Acid—epilepsy syndrome	3.43e-05	0.000214	CcSEcCtD
Ondansetron—Headache—Valproic Acid—epilepsy syndrome	3.41e-05	0.000213	CcSEcCtD
Ondansetron—Paraesthesia—Topiramate—epilepsy syndrome	3.41e-05	0.000213	CcSEcCtD
Ondansetron—Dyspnoea—Topiramate—epilepsy syndrome	3.38e-05	0.000212	CcSEcCtD
Ondansetron—Somnolence—Topiramate—epilepsy syndrome	3.37e-05	0.000211	CcSEcCtD
Ondansetron—Diarrhoea—Pregabalin—epilepsy syndrome	3.37e-05	0.00021	CcSEcCtD
Ondansetron—Hypersensitivity—Gabapentin—epilepsy syndrome	3.32e-05	0.000208	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000205	CcSEcCtD
Ondansetron—Fatigue—Topiramate—epilepsy syndrome	3.27e-05	0.000205	CcSEcCtD
Ondansetron—Dizziness—Pregabalin—epilepsy syndrome	3.25e-05	0.000203	CcSEcCtD
Ondansetron—Pain—Topiramate—epilepsy syndrome	3.24e-05	0.000203	CcSEcCtD
Ondansetron—Constipation—Topiramate—epilepsy syndrome	3.24e-05	0.000203	CcSEcCtD
Ondansetron—Asthenia—Gabapentin—epilepsy syndrome	3.24e-05	0.000202	CcSEcCtD
Ondansetron—Pruritus—Gabapentin—epilepsy syndrome	3.19e-05	0.0002	CcSEcCtD
Ondansetron—Vomiting—Pregabalin—epilepsy syndrome	3.13e-05	0.000196	CcSEcCtD
Ondansetron—Feeling abnormal—Topiramate—epilepsy syndrome	3.13e-05	0.000196	CcSEcCtD
Ondansetron—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.1e-05	0.000194	CcSEcCtD
Ondansetron—Rash—Pregabalin—epilepsy syndrome	3.1e-05	0.000194	CcSEcCtD
Ondansetron—Dermatitis—Pregabalin—epilepsy syndrome	3.1e-05	0.000194	CcSEcCtD
Ondansetron—Diarrhoea—Gabapentin—epilepsy syndrome	3.09e-05	0.000193	CcSEcCtD
Ondansetron—Headache—Pregabalin—epilepsy syndrome	3.08e-05	0.000193	CcSEcCtD
Ondansetron—Urticaria—Topiramate—epilepsy syndrome	3.01e-05	0.000189	CcSEcCtD
Ondansetron—Abdominal pain—Topiramate—epilepsy syndrome	3e-05	0.000188	CcSEcCtD
Ondansetron—Body temperature increased—Topiramate—epilepsy syndrome	3e-05	0.000188	CcSEcCtD
Ondansetron—Dizziness—Gabapentin—epilepsy syndrome	2.98e-05	0.000187	CcSEcCtD
Ondansetron—Vomiting—Gabapentin—epilepsy syndrome	2.87e-05	0.000179	CcSEcCtD
Ondansetron—Rash—Gabapentin—epilepsy syndrome	2.84e-05	0.000178	CcSEcCtD
Ondansetron—Dermatitis—Gabapentin—epilepsy syndrome	2.84e-05	0.000178	CcSEcCtD
Ondansetron—Headache—Gabapentin—epilepsy syndrome	2.83e-05	0.000177	CcSEcCtD
Ondansetron—Hypersensitivity—Topiramate—epilepsy syndrome	2.8e-05	0.000175	CcSEcCtD
Ondansetron—Asthenia—Topiramate—epilepsy syndrome	2.72e-05	0.00017	CcSEcCtD
Ondansetron—Pruritus—Topiramate—epilepsy syndrome	2.68e-05	0.000168	CcSEcCtD
Ondansetron—Diarrhoea—Topiramate—epilepsy syndrome	2.6e-05	0.000162	CcSEcCtD
Ondansetron—Dizziness—Topiramate—epilepsy syndrome	2.51e-05	0.000157	CcSEcCtD
Ondansetron—Vomiting—Topiramate—epilepsy syndrome	2.41e-05	0.000151	CcSEcCtD
Ondansetron—Rash—Topiramate—epilepsy syndrome	2.39e-05	0.00015	CcSEcCtD
Ondansetron—Dermatitis—Topiramate—epilepsy syndrome	2.39e-05	0.000149	CcSEcCtD
Ondansetron—Headache—Topiramate—epilepsy syndrome	2.38e-05	0.000149	CcSEcCtD
Ondansetron—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	3.46e-06	3.79e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	3.45e-06	3.77e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	3.45e-06	3.77e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	3.43e-06	3.75e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.42e-06	3.74e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	3.42e-06	3.74e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.42e-06	3.74e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	3.42e-06	3.73e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.41e-06	3.73e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.4e-06	3.72e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	3.38e-06	3.7e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.37e-06	3.69e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.36e-06	3.68e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.36e-06	3.68e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	3.33e-06	3.64e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.32e-06	3.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.32e-06	3.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.32e-06	3.63e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	3.3e-06	3.61e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	3.3e-06	3.6e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.29e-06	3.6e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.29e-06	3.6e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.28e-06	3.59e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	3.28e-06	3.59e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	3.26e-06	3.57e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	3.22e-06	3.52e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.2e-06	3.5e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	3.2e-06	3.5e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	3.17e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	3.17e-06	3.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.16e-06	3.46e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.16e-06	3.46e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—BCHE—epilepsy syndrome	3.16e-06	3.45e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.15e-06	3.45e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	3.15e-06	3.44e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	3.13e-06	3.42e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	3.12e-06	3.41e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	3.11e-06	3.4e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.11e-06	3.4e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.08e-06	3.37e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.06e-06	3.35e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GPX1—epilepsy syndrome	3.05e-06	3.34e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	3.03e-06	3.31e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.02e-06	3.3e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.01e-06	3.3e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	3.01e-06	3.29e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.01e-06	3.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3e-06	3.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3e-06	3.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3e-06	3.28e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.98e-06	3.26e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.98e-06	3.26e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	2.97e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.97e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TH—epilepsy syndrome	2.97e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TH—epilepsy syndrome	2.96e-06	3.24e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	2.95e-06	3.23e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	2.95e-06	3.22e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.95e-06	3.22e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	2.94e-06	3.21e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.91e-06	3.19e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	2.89e-06	3.16e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	2.88e-06	3.15e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.86e-06	3.13e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.86e-06	3.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	2.84e-06	3.11e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	2.83e-06	3.09e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.81e-06	3.07e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.81e-06	3.07e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.8e-06	3.06e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.8e-06	3.06e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.74e-06	3e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.74e-06	3e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.72e-06	2.98e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.71e-06	2.97e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.7e-06	2.96e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.69e-06	2.94e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	2.69e-06	2.94e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.68e-06	2.93e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.68e-06	2.93e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.64e-06	2.89e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.63e-06	2.88e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.62e-06	2.87e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.62e-06	2.86e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.62e-06	2.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	2.62e-06	2.86e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.61e-06	2.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.61e-06	2.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.6e-06	2.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	2.6e-06	2.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.6e-06	2.84e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.6e-06	2.84e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.58e-06	2.82e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.56e-06	2.8e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	2.55e-06	2.79e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.51e-06	2.75e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	2.5e-06	2.73e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.49e-06	2.72e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	2.48e-06	2.71e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	2.48e-06	2.71e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.47e-06	2.7e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.47e-06	2.7e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAT—epilepsy syndrome	2.44e-06	2.67e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.44e-06	2.67e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	2.43e-06	2.65e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.42e-06	2.64e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.4e-06	2.63e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.4e-06	2.62e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.39e-06	2.62e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-06	2.6e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	2.38e-06	2.6e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.37e-06	2.59e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.37e-06	2.59e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.35e-06	2.57e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.34e-06	2.56e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.29e-06	2.5e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.25e-06	2.46e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.25e-06	2.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.25e-06	2.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.25e-06	2.46e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.24e-06	2.45e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.23e-06	2.44e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.23e-06	2.44e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.22e-06	2.43e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.22e-06	2.43e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GPX1—epilepsy syndrome	2.21e-06	2.42e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.21e-06	2.41e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.2e-06	2.41e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.2e-06	2.41e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	2.19e-06	2.4e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	2.19e-06	2.39e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.17e-06	2.37e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.17e-06	2.37e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.16e-06	2.36e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.14e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.14e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.12e-06	2.32e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.11e-06	2.31e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TH—epilepsy syndrome	2.11e-06	2.3e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.1e-06	2.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TH—epilepsy syndrome	2.09e-06	2.28e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.07e-06	2.27e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.07e-06	2.26e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.06e-06	2.25e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.05e-06	2.25e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	2.04e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.01e-06	2.2e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2e-06	2.19e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2e-06	2.18e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.94e-06	2.12e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.94e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.93e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.91e-06	2.08e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.9e-06	2.08e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.9e-06	2.08e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.9e-06	2.07e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.89e-06	2.07e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.85e-06	2.03e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.85e-06	2.02e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.84e-06	2.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.81e-06	1.98e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	1.8e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.8e-06	1.96e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.79e-06	1.96e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.78e-06	1.95e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TH—epilepsy syndrome	1.78e-06	1.95e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.77e-06	1.93e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.76e-06	1.93e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.76e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.76e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	1.91e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.74e-06	1.9e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.73e-06	1.9e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.72e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.72e-06	1.88e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.71e-06	1.87e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.69e-06	1.85e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.68e-06	1.84e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	1.83e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.67e-06	1.83e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.64e-06	1.79e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.63e-06	1.78e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.63e-06	1.78e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.62e-06	1.77e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.6e-06	1.75e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	1.57e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.57e-06	1.72e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.56e-06	1.7e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.56e-06	1.7e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.55e-06	1.7e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.55e-06	1.69e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.53e-06	1.68e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.52e-06	1.66e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.49e-06	1.63e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.48e-06	1.62e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.47e-06	1.61e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.47e-06	1.61e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.46e-06	1.6e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.43e-06	1.56e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	1.41e-06	1.54e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.41e-06	1.54e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.4e-06	1.53e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.4e-06	1.53e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TH—epilepsy syndrome	1.38e-06	1.51e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.38e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.38e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.36e-06	1.49e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.36e-06	1.49e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.35e-06	1.47e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.34e-06	1.46e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.33e-06	1.45e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.32e-06	1.45e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.3e-06	1.42e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.3e-06	1.42e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.28e-06	1.4e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.22e-06	1.33e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.19e-06	1.3e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.17e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.16e-06	1.27e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.15e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.14e-06	1.25e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.13e-06	1.24e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.1e-06	1.21e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.06e-06	1.15e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.05e-06	1.14e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.03e-06	1.12e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	9.95e-07	1.09e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—epilepsy syndrome	9.81e-07	1.07e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	9.23e-07	1.01e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	9.15e-07	1e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AKT1—epilepsy syndrome	9.03e-07	9.87e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.99e-07	9.83e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.94e-07	9.78e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.81e-07	9.64e-06	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	8.78e-07	9.6e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.82e-07	8.55e-06	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	7.58e-07	8.29e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.57e-07	8.28e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.9e-07	7.55e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKT1—epilepsy syndrome	6.54e-07	7.15e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKT1—epilepsy syndrome	6.53e-07	7.14e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.04e-07	6.6e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.64e-07	5.08e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.6e-07	5.03e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.93e-07	4.3e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.03e-07	3.32e-06	CbGpPWpGaD
